218 related articles for article (PubMed ID: 25168834)
1. Mechanisms of disease reversal in focal and segmental glomerulosclerosis.
Yang HC; Fogo AB
Adv Chronic Kidney Dis; 2014 Sep; 21(5):442-7. PubMed ID: 25168834
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy.
Durvasula RV; Shankland SJ
Curr Hypertens Rep; 2006 May; 8(2):132-8. PubMed ID: 16672146
[TBL] [Abstract][Full Text] [Related]
3. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.
Zhang J; Yanez D; Floege A; Lichtnekert J; Krofft RD; Liu ZH; Pippin JW; Shankland SJ
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):234-48. PubMed ID: 25143333
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.
Ueno T; Kobayashi N; Nakayama M; Takashima Y; Ohse T; Pastan I; Pippin JW; Shankland SJ; Uesugi N; Matsusaka T; Nagata M
Kidney Int; 2013 Jun; 83(6):1065-75. PubMed ID: 23447065
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
7. Compound effects of aging and experimental FSGS on glomerular epithelial cells.
Schneider RR; Eng DG; Kutz JN; Sweetwyne MT; Pippin JW; Shankland SJ
Aging (Albany NY); 2017 Feb; 9(2):524-546. PubMed ID: 28222042
[TBL] [Abstract][Full Text] [Related]
8. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice.
Peten EP; Striker LJ; Fogo A; Ichikawa I; Patel A; Striker GE
Mol Med; 1994 Nov; 1(1):104-15. PubMed ID: 8790606
[TBL] [Abstract][Full Text] [Related]
11. Modulation of glomerulosclerosis.
Ma LJ; Fogo AB
Semin Immunopathol; 2007 Nov; 29(4):385-95. PubMed ID: 17828397
[TBL] [Abstract][Full Text] [Related]
12. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
13. Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?
Moeller MJ
Nephrol Dial Transplant; 2010 Jul; 25(7):2101-3. PubMed ID: 20388634
[No Abstract] [Full Text] [Related]
14. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
15. Parietal epithelial cells and podocytes in glomerular diseases.
Smeets B; Moeller MJ
Semin Nephrol; 2012 Jul; 32(4):357-67. PubMed ID: 22958490
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
[TBL] [Abstract][Full Text] [Related]
17. [Glomerulosclerosis: pathogenetic mechanisms and possibility of regression].
Faraggiana T; Giannakakis C
G Ital Nefrol; 2008; 25 Suppl 44():S27-S32. PubMed ID: 19048583
[TBL] [Abstract][Full Text] [Related]
18. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of focal segmental glomerulosclerosis.
Jefferson JA; Shankland SJ
Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
[TBL] [Abstract][Full Text] [Related]
20. Reducing mTOR augments parietal epithelial cell density in a model of acute podocyte depletion and in aged kidneys.
McNicholas BA; Eng DG; Lichtnekert J; Rabinowitz PS; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F626-39. PubMed ID: 27440779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
